noom vs hims glp-1 The Engagement Report: New Data Shows that the Patients Who Use Noom the Most Also Lose the Most Weight and Stay On Medication Program Longest Noom Launches Microdose GLP-1 Program,

Efficacy and safety of once-weekly semaglutide 1.0mg vs once-daily liraglutide 1.2mg as add-on to 13 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)

Notable Paragraph IV Outcomes Tevas challenge to Pfizers atorvastatin patents (Lipitor) is the canonical success story

At least 39 newer, better GLP-1 drugs are in trial or under development (!)

Rewarded for its Research Since 2010, the New Zealand government has funded $30 million for the development of a gut-targeted plant-based nutraceutical for appetite control with Plant and Food Research (PFR), a government-owned Crown Research Institute

you feel fuller for much longer periods

Does semaglutide increase my risk of another diverticulitis attack